Key takeaways
To switch from the Wegovy injection to the pill, you’ll need to get an updated prescription from your healthcare provider.
The switch itself is typically straightforward: You start taking the Wegovy pill daily one week after your last injection.
To ease the transition, it’s important to take the pill exactly as described, continue exercising and eating a healthy diet, and stay in touch with your healthcare provider.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
To switch from the Wegovy injection to the pill, you’ll need to get an updated prescription from your healthcare provider.
The switch itself is typically straightforward: You start taking the Wegovy pill daily one week after your last injection.
To ease the transition, it’s important to take the pill exactly as described, continue exercising and eating a healthy diet, and stay in touch with your healthcare provider.
Are you considering switching from the Wegovy injection to the pill? You’re not alone. Prescriptions for the Wegovy pill have soared since it was released in early 2026.
Generally, switching from Wegovy injection to the pill is fairly straightforward, but there are a few things to keep in mind to ensure a smooth transition. Read on as we break down everything you need to know.
Why consider switching from Wegovy injection to the pill?
There are many reasons to consider switching from the Wegovy injection to the pill, whether needles make you squeamish or you’re looking for a more cost-effective weight loss option. For example:
You simply don’t like injections or have a fear of needles. The Wegovy pill offers a needle-free alternative.
You find it easier to keep up with a daily rather than a weekly routine. The Wegovy pill is taken daily, while the injection is administered weekly.
You’ve been experiencing skin sensitivity and reactions from the injection, such as redness, pain, or itching. The Wegovy pill and injection share similar side effects, but only the injection produces injection site reactions.
You travel often. It can be easier to travel with the Wegovy pill vs. the injection, since you don’t have to worry about keeping the pill refrigerated or declaring needles at TSA.
You’re paying cash for your prescription. When opting for self-pay on Ro, the Wegovy pill costs $149–$299 per month, while the Wegovy injection costs $199–$349 per month*.
Your insurance covers the pill, but not the injection. Insurers can vary in their coverage of GLP-1s in general, and some only cover one form of Wegovy.
*Terms and restrictions may apply for certain doses; see more here
How to switch from Wegovy injection to the pill
You should never switch from the Wegovy injection to the pill on your own. Your first step is always to talk to your healthcare provider. If they determine that trading the pen for the pill is a good option, here’s what you can typically expect:
1. Take your last Wegovy injection as usual.
2. Wait one week.
3. Instead of taking your injection as you normally would, take your first dose of the Wegovy pill.
4. Continue taking the Wegovy pill daily, first thing in the morning on an empty stomach, at least 30 minutes before food, beverages, or other medications.
When switching from the Wegovy injection to the pill, your healthcare provider will write you a new prescription for the pill. They’ll let you know if you can expect any dosage changes, depending on what dose you were taking of the Wegovy injection and your experience with side effects.
9 tips for switching from Wegovy injection to pill safely and smoothly
Follow these tips for a smooth transition from the Wegovy injection to the pill.
1. Wait 7 days between your last shot and your first pill
Even though the pill is taken daily, you need to wait one week after your last injection before starting the Wegovy pill.
That’s because the Wegovy injection has a high bioavailability (how much of the drug enters your system after taking it) and takes a few days to reach peak concentration in your bloodstream. The pill, on the other hand, has a low bioavailability of only 1%–2% (vs. pen’s 89%), which is why it needs to be taken daily to maintain a steady level in your body.
If you start taking the Wegovy pill sooner than one week later, you run the risk of having too much Wegovy in your body. This can lead to more intense and possibly serious side effects.
2. Take the Wegovy pill as directed
The Wegovy pill and injection are taken differently, and we’re not just talking about the fact that one is a daily pill and the other is a weekly injection. In order for the Wegovy pill to work effectively, you must follow strict timing requirements around dosing.
For the pill to be properly absorbed, you must:
Take it first thing in the morning on an empty stomach.
Swallow it whole with up to 4 ounces of water (and no more).
Wait at least 30 minutes before you eat, drink, or take other medications.
3. Do not “double up” on doses of Wegovy
When switching between the Wegovy injection and pill, do not:
Take a dose of the Wegovy injection and the pill on the same day.
Take a dose of the Wegovy pill earlier than one week after your last injection.
Take more than one dose of the Wegovy pill.
If you forget to take your first dose of the Wegovy pill on the scheduled day (i.e. one week after your last injection), take it the following morning on an empty stomach.
If you miss a dose of the Wegovy pill in the future, simply skip the missed dose and take your next dose the following day as usual.
4. Store the Wegovy pill properly
The Wegovy pill also has different storage requirements than the injection. Specifically, the tablets must be stored in their original container — not in a personal pill organizer. The original bottle is specially designed to protect them from moisture, so keep the lid closed.
Store the pills at room temperature (68°F–77°F or 20°C–25°C) in a dry place, such as your bedside table (so it’s easy to reach for in the morning).
5. Follow your healthcare provider’s guidance for other medications
Because the Wegovy pill must be taken on an empty stomach in the morning, at least 30 minutes before anything else, you may need to move around the dosing times of any other medications in your regimen.
If needed, your healthcare provider can help you create a new dosing schedule. They may recommend:
Waiting until the 30 minutes have passed to take your other morning medications.
Moving some morning medications to the evening.
Taking one or more of your other medications at different times during the day.
If you are taking other drugs that should be taken on an empty stomach, such as levothyroxine, ask your healthcare provider how you should time your dose with Wegovy.
6. Adjust your morning routine
For the Wegovy pill to work effectively, it’s important to take it consistently in the morning as soon as you wake up — on an empty stomach, at least 30 minutes before food, drinks, or other medications (it bears repeating).
To make sure you take the Wegovy pill as directed, it can be helpful to make some slight tweaks to your morning routine. For example, you might:
Update the text on your alarm to say something like, “Take Wegovy!”
Use your phone’s reminder app as an alarm and have it remind you to take your pill.
Pair your dose with something you consistently do as soon as you wake up, such as a morning meditation or heating up your tea kettle (just don’t drink any yet!).
Set a 30-minute timer after you take your dose so you don’t drink coffee or eat breakfast until the time is up.
Pour yourself 4 ounces of water the night before and leave it on your nightstand to take with your dose.
7. Prepare for (and track) possible side effects
Your healthcare provider will use their discretion to prescribe an equivalent dose of the Wegovy pill, so you may not notice any changes in side effects. However, some people do experience slightly more gastrointestinal (GI) side effects on the Wegovy pill vs. the injection.
It’s also possible to experience a slight increase in GI side effects when switching GLP-1s in general, but these are usually temporary and go away on their own.
Keep a log of anything that feels different or new. If it doesn’t go away or gets worse, contact your healthcare provider.
To be safe, you can take a little extra care to avoid stomach upset from the Wegovy pill:
Limit fatty, fried, and processed foods.
Stay hydrated by drinking water and eating water-rich foods (e.g. soup, low-fat yogurt).
Consider eating blander foods until you’re used to the Wegovy pill, such as crackers, apples, chicken broth, or rice.
Eat smaller portions more frequently during the day as opposed to fewer, larger meals.
8. Keep up with healthy lifestyle changes
When switching to the Wegovy pill, it’s important to continue the healthy lifestyle habits you started while taking the injection, such as diet and exercise.
Diet: Eating a Wegovy-friendly diet not only supports weight loss, but it can help you avoid some of the more bothersome side effects, too. For example, avoiding fatty, fried, and processed foods can help minimize nausea.
Exercise: For people taking Wegovy for weight loss, experts recommend a combination of moderate-to-high intensity cardio with regular strength training.
Research shows that people who implement these healthy habits tend to experience better Wegovy weight loss results than those who don’t.
9. Lean on your healthcare provider if necessary
When switching from injectable to oral Wegovy, it’s a good idea to stay in regular contact with your healthcare provider. Don’t hesitate to contact them if you experience any unexpected changes or have any concerns regarding:
Your weight loss progress
Challenges with taking your dose on schedule
What to expect when switching from Wegovy injection to the pill
The switch from the Wegovy injection to the pill is usually uneventful. Here’s a high-level overview of what you can expect:
Slight changes in side effects. Wegovy’s side effects are similar between the pill and the injection, with one exception. If you were experiencing skin reactions from the shot, those should go away now that you’re on the pill. Also, some people may experience slightly more GI upset on the pill, but your body should adjust with time.
A new morning routine. Now, the very first thing you should do upon waking up is take your Wegovy pill. And you’ll need to wait at least 30 minutes before eating, drinking, or taking other medications.
Possible change in appetite and cravings. The Wegovy pill and injection share the same ingredient, but they’re absorbed differently. So it’s possible you might experience slight changes as your body adjusts to the oral version.
Continued weight loss progress. Your healthcare provider should switch you to an equivalent dose of the pill, so your body can maintain a steady level of semaglutide. However, if the Wegovy injection caused you very intense side effects, they may want to switch you to a lower dose of the pill.
Wegovy injection to Wegovy pill dose conversion
If you’ve been taking 2.4 mg of the Wegovy injection, your healthcare provider may switch you to the 25 mg maintenance dose of the Wegovy pill. You can typically start it one week after your last injection, and then take the Wegovy pill each day moving forward.
There are no official conversion instructions for switching from lower doses of the injection to the pill. So, if you’re taking a lower dose of Wegovy (e.g. 0.25 mg, 0.5 mg, 1 mg, or 1.7 mg), your healthcare provider will use their discretion to switch you to an appropriate dose of the Wegovy pill, based on your response to the injection and tolerance for side effects.
Can I switch back to the Wegovy injection if the pill doesn’t work for me?
You may find that after switching from the injection to the pill, you prefer the injection. That’s okay. You can switch back to the Wegovy injection from the pill as long as you do so under the guidance and supervision of a healthcare provider.
Some people switch back because they find it easier to stick to the weekly routine, or they experience worse side effects with the pill. (Others may feel like they’re not losing weight on the Wegovy pill and prefer the faster, slightly higher results that tend to come with the injection.)
Whatever the reason, talk about it with your healthcare provider. They may recommend sticking it out a bit longer with the pill to see if your weight loss picks up or your side effects subside. They may also offer pointers on adhering to the morning routine or try switching you to a lower dose of the pill. Or it might make sense to switch you right back to the injection.
Bottom line
If you want to switch from the Wegovy injection to the pill, your first step is to contact a healthcare provider. They can help determine whether moving from pen to pill is right for you and, if so, write you a new prescription and help you manage the transition. Until then, here’s what to remember:
People switch from the Wegovy injection to the pill for various reasons, including convenience, cost savings, or a fear of needles.
When you’re ready to make the switch, you’ll use your last injection of Wegovy, start the pill one week later, and then continue taking the pill daily moving forward.
For a smooth transition from the injection to the pill, follow all instructions regarding dose timing and storage, rework your morning routine, keep up with diet and exercise, and reach out to your healthcare provider if you have any questions or concerns.
Switching from the Wegovy injection to the pill may lead to some temporary, slight changes in GI side effects or appetite, but these should go away on their own as your body adjusts.
If you find the Wegovy pill doesn’t work for you, you can always switch back to the injection or try another GLP-1 entirely.
Frequently asked questions (FAQs)
Can you switch from the Wegovy injection to the pill?
Yes, you can typically switch from the Wegovy injection to the pill — that is, as long as you’re under the care and supervision of a healthcare provider. Here’s how the switch typically goes:
You'll take your last dose of the Wegovy injection.
One week after your last injection, you’ll take your first dose of the Wegovy pill.
You’ll take the pill daily moving forward.
Your healthcare provider will need to write you a new prescription for the weight loss pill. You can get a prescription for the Wegovy pill online (such as on Ro) or meet with a healthcare provider in person.
Is the Wegovy pill as effective as the injection?
The Wegovy pill produces similar results to the injection, but the injection is still slightly more effective. No studies have directly compared the two. But separate studies show that the pill can produce an average 64-week weight loss of 13.6%, while the injection can produce an average 72-week weight loss of 15.6% on the 2.4 mg dose and 18.7% on the 7.2 mg HD dose.
Can you switch from injectable to oral semaglutide?
Yes, you can switch from injectable to oral semaglutide — as long as your healthcare provider gives you the green light.
If you’re on the maintenance dose of the semaglutide injection, your healthcare provider may switch you to the maintenance dose of oral semaglutide. You’ll need a new prescription for oral semaglutide.
Does the Wegovy pill make you feel different from the shot?
In general, no. The Wegovy pill and the shot work the same way and contain the same active ingredient. Some people may experience slightly more digestive side effects on the pill, but these should lessen with time as your body adjusts. And there are no injection site reactions (i.e. redness, pain, itching) on the pill, since you take it by mouth.
Do you need a new prescription to switch from Wegovy injection to the pill?
Yes, you need a new prescription to switch from the Wegovy injection to the pill. Even though they contain the same active ingredient, they have different National Drug Code (NDC) numbers and come in different dosage strengths.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
References
Chao, A. M., Tronieri, J. S., Amaro, A., et al. (2022). Clinical insight on semaglutide for chronic weight management in Adults: Patient selection and special considerations. Drug Design Development and Therapy, 16, 4449–4461. doi: 10.2147/dddt.s365416. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9807016/
Conti, M., Pontiggia, L., Vergani, M., et al. (2024). Comparing medication persistence with oral and subcutaneous semaglutide in a real-world setting. Acta Diabetologica, 62(7), 1065–1072. doi: 10.1007/s00592-024-02424-9. Retrieved from https://pubmed.ncbi.nlm.nih.gov/39680131/
Gorgojo-Martínez, J. J., Mezquita-Raya, P., Carretero-Gómez, J., et al. (2022). Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of Clinical Medicine, 12(1), 145. doi: 10.3390/jcm12010145. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9821052/
Houle, C., Gelhorn, H., Cutts, K., et al. (2026). Patient preferences for pharmacological treatments for obesity: The VOICE study. Obesity Pillars, 19, 100278. doi: 10.1016/j.obpill.2026.100278. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC13231064/
Jain, A. B., Ali, A., Martínez, J. J. G., et al. (2020). Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance. International Journal of Clinical Practice, 75(2), e13731. doi: 10.1111/ijcp.13731. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7900946/
Liu, A., Dunleavy, K., & Kansteiner, F. (2026). The Oral GLP-1 Tracker: Obesity prescriptions jump for both Novo and Lilly. Fierce Pharma. Retrieved from https://www.fiercepharma.com/pharma/oral-glp-1-tracker-launch-trajectories-lilly-foundayo-novo-wegovy-pill
Liu, L., Cui, J., Neidecker, M. V., et al. (2025). Tirzepatide vs semaglutide and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States. Journal of Managed Care & Specialty Pharmacy, 31(5), 441–450. doi: 10.18553/jmcp.2025.31.5.441. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12039506/
novoMEDLINK-a. (2026). Dosing & Administration: Administration for pen or pill: A guide for HCPs. retrieved from https://www.novomedlink.com/obesity/products/treatments/wegovy/dosing-administration/the-wegovy-pen-pill.html
novoMEDLINK-b. (2026). Dosing & Administration: Prescribing Wegovy® and Wegovy® HD (semaglutide) injection 7.2 mg. Retrieved from https://www.novomedlink.com/obesity/products/treatments/wegovy/dosing-administration/prescribing.html
Rubino, D., Wharton, S., Knight, M. G., et al. (2026). Evidence-informed guidance for the clinical use of oral semaglutide in obesity management. Postgraduate Medicine, 138(6), 654–664. doi: 10.1080/00325481.2026.2686467. Retrieved from https://pubmed.ncbi.nlm.nih.gov/42286992/
Transportation Security Administration (TSA). (n.d.) Travel Tips. U.S. Department of Homeland Security. https://www.tsa.gov/travel/travel-tips
U.S. Food and Drug Administration (FDA). (2026). Highlights of Prescribing Information: Wegovy (semaglutide) injection, for subcutaneous use Wegovy (semaglutide) tablets for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s025lbl.pdf
Wharton, S., Freitas, P., Hjelmesæth, J., et al. (2025). Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial. The Lancet Diabetes & Endocrinology, 13(11), 949–963. doi: 10.1016/s2213-8587(25)00226-8. Retrieved from https://pubmed.ncbi.nlm.nih.gov/40961952/
Wharton, S., Lingvay, I., Bogdanski, P., et al. (2025). Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. New England Journal of Medicine, 393(11), 1077–1087. doi: 10.1056/nejmoa2500969. Retrieved from https://www.nejm.org/doi/10.1056/NEJMoa2500969
Zhang, J., Wang, X., & Zhou, Y. (2024). Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration. Frontiers in Pharmacology, 15, 1471615. doi: 10.3389/fphar.2024.1471615. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11534668/














